BloodBankGuy

We use "Titer too low to measure: Enhancment reagents used for antibody identification are not recommended for titers."  We do not enhance our titers as we do antibody identifications to prevent falsly high titers.  We treat it as in vivo where we see how it demonstrates without the addition of enhancment reagents.

If you attend any Medicare billing conferences they discuss this in detail.  You can only charge for an antigen typing to one patient.  Now if you want to charge it to the patient you initially screened  OR the patient that is receiving it if the first didn't need it that is fine, but charging bothing for something you have done once is a mischarge.  At least that is how it is discribed.

If you attend any Medicare billing conferences they discuss this in detail.  You can only charge for an antigen typing to one patient.  Now if you want to charge it to the patient you initially screened  OR the patient that is receiving it if the first didn't need it that is fine, but charging bothing for something you have done once is a mischarge.  At least that is how it is discribed.

If you attend any Medicare billing conferences they discuss this in detail.  You can only charge for an antigen typing to one patient.  Now if you want to charge it to the patient you initially screened  OR the patient that is receiving it if the first didn't need it that is fine, but charging bothing for something you have done once is a mischarge.  At least that is how it is discribed.

We use "Titer too low to measure: Enhancment reagents used for antibody identification are not recommended for titers."  We do not enhance our titers as we do antibody identifications to prevent falsly high titers.  We treat it as in vivo where we see how it demonstrates without the addition of enhancment reagents.

If you attend any Medicare billing conferences they discuss this in detail.  You can only charge for an antigen typing to one patient.  Now if you want to charge it to the patient you initially screened  OR the patient that is receiving it if the first didn't need it that is fine, but charging bothing for something you have done once is a mischarge.  At least that is how it is discribed.

Our blood bank policy is if there has not been a transfusion in 3 months we would not do the elution.  Granted if you do not have any previous history on the patient you are relying on their word, but its not like you are asking if they took a certain medication that they may or may not remember.  Most patients, will remember if they received a transfusion or not.
 
Now I have some older techs that will still run one to see, and if we have a patient that looks to be a WARM auto we will run one, but in general we don't unless proof of transfusion
 
But there is a small possibility that you have bad intel as goodchild said and you may miss something.  Kind of a judgement call.

Our pathologist does not have input in the identification of antibodies and they do not review the records after.  Significant/insignificant is made by the supervisor (Me) if there is any question as to whether it is or not.  Granted it's easy as 98% of antibodies are significant that are identified on a daily basis.  But as I said no pathologist comments on antibody identification.

Interesting enough my hospital had a situation just like this less than a year ago.  We were not informed of the bone marrow transplant but saw that the doctor was an oncologist and when we typed them (previous and we saw they were now an A, we thought we needed to do some digging.  When we finally found out that they had a transplant we gave them O cells as we could not fix the ABO discrepancy even though we had a reason why. 
 
As Shily said, O cells are not rare so we kept as such to not cause any potential effects since no one had ever experienced something like this before. 

Our pathologist does not have input in the identification of antibodies and they do not review the records after.  Significant/insignificant is made by the supervisor (Me) if there is any question as to whether it is or not.  Granted it's easy as 98% of antibodies are significant that are identified on a daily basis.  But as I said no pathologist comments on antibody identification.

Yes SMILLER but that is talking about reissuing.  At no time was this unit reissued.  It was never returned to blood bank, so this would not apply to this situation.  We would never have accepte this unit back under the current conditions of it being spiked.  The nurse never handed over the blood when he walked down with it.